Back
Allakos 10K Form
Sell
45
ALLK
Allakos
Last Price:
1.23
Seasonality Move:
-15.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | ALLK/Allakos Quarterly |
| 2020-05-11 | 10Q | ALLK/Allakos Quarterly |
| 2020-02-25 | 10K | ALLK/Allakos Annual |
| 2019-11-12 | 10Q | ALLK/Allakos Quarterly |
| 2019-08-05 | 10Q | ALLK/Allakos Quarterly |
| 2019-05-08 | 10Q | ALLK/Allakos Quarterly |
Receive ALLK News And Ratings
See the #1 stock for the next 7 days that we like better than ALLK
ALLK Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-31.73M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.81 |
| Price / Book: | 1.59 |
Profitability
| EPS (TTM): | -2.04000 |
|---|---|
| Net Income (TTM): | $-178.75M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Allakos Earnings Forecast
Key Allakos Financial Ratios
- The Interest Expense is -5.52% of Operating Income.
- Per Share Earnings over the last 8 years have been positive in 2 years.
Allakos Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALLK |
| CUSIP: | 01671P |
| Website: | allakos.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |